Head-to-Head

Ginkgo Bioworks Holdings, Inc. vs. Moderna, Inc. Common Stock

DNA

Ginkgo Bioworks Holdings, Inc.

$8.44 +1.44%

VS MRNA

Moderna, Inc. Common Stock

$199.33 +1.29%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

DNAMRNA
Market Cap $539.34 million $79.63 billion

MRNA leads on 1 of 1 size & scale factors.

Risk & Sentiment

DNAMRNA
Short Interest 19.24% 0.01%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: DNA overview, DNA financials, MRNA overview, MRNA financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.